Critical oncology trial data remains hidden
Despite a commitment from the pharmaceutical industry in 2014 to improve data transparency, more than half of the clinical trials that led to the United States […]
Obesity ‘buffer’ in lung cancer therapy: research
Above average or high BMI – often linked to cancers, diabetes, cardiovascular and other diseases – may in some cases improve the chance of surviving certain […]